EMD-31558

Single-particle
2.95 Å
EMD-31558 Deposition: 21/07/2021
Map released: 27/10/2021
Last modified: 26/10/2022
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-31558

Archive Files (Depositor)

Primary 3D volume (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-7fen summary report (pdf.gz) Map-7fen FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

Structure of human SGLT2-MAP17 complex bound with empagliflozin

EMD-31558

Single-particle
2.95 Å
EMD-31558 Deposition: 21/07/2021
Map released: 27/10/2021
Last modified: 26/10/2022
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: human soluble guanylate cyclase
Fitted models: 7fen

Deposition Authors: Chen L , Niu Y, Liu R
Structural basis of inhibition of the human SGLT2-MAP17 glucose transporter.
Niu Y, Liu R , Guan C, Zhang Y , Chen Z , Hoerer S, Nar H , Chen L
(2022) Nature , 601 , 280 - 284
PUBMED: 34880493
DOI: doi:10.1038/s41586-021-04212-9
ISSN: 1476-4687
ASTM: NATUAS